BACKGROUND AND PURPOSE: Predicting stroke using biomarkers would enable clinicians to help prevent stroke or mitigate damage. Several stroke biomarkers have been investigated but none has shown near term predictive value. METHODS: We studied patients presenting with a history of stroke or transient ischemic attack (TIA) to determine whether serum levels of autoantibodies to the NMDA receptor NR2 peptide (NR2Ab) reflected the presence of recent stroke compared with controls. Antibody levels were also correlated with clinical risk factors for stroke, including diabetes, hypertension, hyperlipidemia, and history of recent TIA or stroke. RESULTS: Of the 245 patients that presented with acute stroke or TIA, 130 consented to participate and results are available for the 120. Volunteers from the community were recruited as controls. Males and females with multiple recent strokes and females with acute strokes had elevated NR2Ab levels compared to non-stroke patients or controls. Using a multiple regression model, the predictive value for NR2Ab was compared to clinical risk factors. In men, the presence of stroke correlated with hypertension (p<0.001) and NR2Ab levels (p<0.01) and in women the presence of stroke correlated with hypertension (p<0.001), diabetes (p<0.05), atrial fibrillation (p<0.05) and NR2Ab (p<0.01). CONCLUSION: These results suggest that NR2Ab levels reflect a history of multiple strokes and may serve as a predictive factor for stroke.
BACKGROUND AND PURPOSE: Predicting stroke using biomarkers would enable clinicians to help prevent stroke or mitigate damage. Several stroke biomarkers have been investigated but none has shown near term predictive value. METHODS: We studied patients presenting with a history of stroke or transient ischemic attack (TIA) to determine whether serum levels of autoantibodies to the NMDA receptor NR2 peptide (NR2Ab) reflected the presence of recent stroke compared with controls. Antibody levels were also correlated with clinical risk factors for stroke, including diabetes, hypertension, hyperlipidemia, and history of recent TIA or stroke. RESULTS: Of the 245 patients that presented with acute stroke or TIA, 130 consented to participate and results are available for the 120. Volunteers from the community were recruited as controls. Males and females with multiple recent strokes and females with acute strokes had elevated NR2Ab levels compared to non-strokepatients or controls. Using a multiple regression model, the predictive value for NR2Ab was compared to clinical risk factors. In men, the presence of stroke correlated with hypertension (p<0.001) and NR2Ab levels (p<0.01) and in women the presence of stroke correlated with hypertension (p<0.001), diabetes (p<0.05), atrial fibrillation (p<0.05) and NR2Ab (p<0.01). CONCLUSION: These results suggest that NR2Ab levels reflect a history of multiple strokes and may serve as a predictive factor for stroke.
Authors: L Servaas Dolmans; Frans H Rutten; Niels C T Koenen; Marie-Louise E L Bartelink; Johannes B Reitsma; L Jaap Kappelle; Arno W Hoes Journal: Cerebrovasc Dis Date: 2019-08-30 Impact factor: 2.762
Authors: Sterling B Ortega; Ibrahim Noorbhai; Katie Poinsatte; Xiangmei Kong; Ashley Anderson; Nancy L Monson; Ann M Stowe Journal: Discov Med Date: 2015-05 Impact factor: 2.970
Authors: Grant C O'Connell; Kyle B Walsh; Emily Burrage; Opeolu Adeoye; Paul D Chantler; Taura L Barr Journal: Physiol Genomics Date: 2018-07-20 Impact factor: 3.107
Authors: Maggie L Kalev-Zylinska; Wymond Symes; Kevin C E Little; Peng Sun; Daying Wen; Linzi Qiao; Deborah Young; Matthew J During; P Alan Barber Journal: Stroke Date: 2013-05-30 Impact factor: 7.914
Authors: Mitchell S V Elkind; Amelia K Boehme; Craig J Smith; Andreas Meisel; Marion S Buckwalter Journal: Stroke Date: 2020-09-08 Impact factor: 7.914
Authors: Svetlana A Dambinova; Kerstin Bettermann; Theodore Glynn; Matthew Tews; David Olson; Joseph D Weissman; Richard L Sowell Journal: PLoS One Date: 2012-07-27 Impact factor: 3.240